Literature DB >> 2853944

Estrogen as adjuvant treatment of Tourette syndrome.

R Sandyk1, C R Bamford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2853944     DOI： 10.1016/0887-8994(87)90042-7

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


× No keyword cloud information.
  3 in total

Review 1.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Estrogen and brain vulnerability.

Authors:  Iñigo Azcoitia; Lydia L Doncarlos; Luis M Garcia-Segura
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.